Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of different anesthesia methods on postoperative recovery and prognosis of patients with colorectal tumors
ChiCTR2100053586Phase 4Not yet recruiting
- Sponsor
- Changhai Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in colorectal cancer (CRC) (4 arms), sponsored by Changhai Hospital. Primary endpoints: Plasma NETosis-specific markers (MPO and H3Cit) and Tumor progression and metastasis related markers (VEGF-A, MMP-3, MMP-9). Planned start Jan 2022; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2100053586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053586.